Jove
Visualize
Contact Us

Related Experiment Videos

IB-MECA and cardioprotection.

Zhelong Xu1, Yeongho Jang, Robert A Mueller

  • 1Department of Anesthesiology, The University of North Carolina at Chapel Hill, NC, USA. ZXu@aims.unc.edu

Cardiovascular Drug Reviews
|January 12, 2007
PubMed
Summary

The adenosine A(3) receptor agonist IB-MECA shows promise in protecting the heart from ischemia/reperfusion injury. Further research is needed to optimize its therapeutic strategy for acute myocardial infarction treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zinc transporters and cardiac pathophysiology.

Free radical biology & medicine·2026
Same author

ZIP14 upregulation leads to ferroptosis and lysosomal dysfunction through intracellular iron overload and induces myocardial ischemia/reperfusion injury in mouse hearts.

Journal of molecular and cellular cardiology·2025
Same author

Downregulation of the Zinc Transporter ZIP13 (Slc39a13) Leads to Ferroptosis by Inhibiting Mitochondrial Iron-Sulfur Cluster Biosynthesis and Induces Ischemia/Reperfusion Injury in Mouse Hearts.

Antioxidants & redox signaling·2025
Same author

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines.

Biosafety and health·2025
Same author

ZIP7 contributes to the pathogenesis of diabetic cardiomyopathy by suppressing mitophagy in mouse hearts.

Cardiovascular diabetology·2024
Same author

PIAS3 acts as a zinc sensor under zinc deficiency and plays an important role in myocardial ischemia/reperfusion injury.

Free radical biology & medicine·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Cardiology
  • Pharmacology
  • Biochemistry

Background:

  • The adenosine A(3) receptor is crucial for ischemic preconditioning.
  • Adenosine A(3) receptor agonists trigger pharmacological preconditioning via multiple mechanisms.

Purpose of the Study:

  • To evaluate the cardioprotective effects of IB-MECA, a potent and selective adenosine A(3) receptor agonist.
  • To explore the potential of IB-MECA in treating myocardial ischemia/reperfusion injury and acute myocardial infarction.

Main Methods:

  • Administration of IB-MECA before ischemia and at the onset of reperfusion.
  • Assessment of cardioprotection against myocardial ischemia/reperfusion injury.

Main Results:

  • IB-MECA induces early and late pharmacological preconditioning.

Related Experiment Videos

  • IB-MECA provides cardioprotection when administered before ischemia or at reperfusion onset.
  • Potential therapeutic utility for acute myocardial infarction.

    • Conclusions:

    • IB-MECA demonstrates significant cardioprotective potential against myocardial ischemia/reperfusion injury.
    • Further studies are required to establish optimal treatment strategies and mitigate potential adverse effects like systemic hypertension and lethality at high concentrations.